Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 5, 2017

Cognitive Impairment, Cerebellar Lesions in MS

  • MS Research Study and Reports
    /
Oct 3, 2017 A specific pattern of cerebellar lesions involving the middle cerebellar peduncle (MCP), rather than the total cerebellar…
MS Research Study and Reports

October 5, 2017

MS Symptom Severity and Patient-Rated Health

  • MS Research Study and Reports
    /
Oct 3, 2017 Pain contributed the most to multiple sclerosis (MS) outpatients’ perception of health, followed by gait dysfunction and…
MS Research Study and Reports

October 5, 2017

Retinal Differences in Persons with MS Examined

  • MS Research Study and Reports
    /
Oct 3, 2017 The largest and most robust differences between the eyes of people with multiple sclerosis (MS) and control…
MS Research Study and Reports

October 5, 2017

This is a clinical trial for Patients with Urinary Incontinence, who have Multiple Sclerosis…

  • Misc. Research Reports
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
                                   If you or…
Misc. Research Reports

October 4, 2017

Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL

  • MS Drug Therapies
    /
JERUSALEM–(BUSINESS WIRE)–Oct. 4, 2017– Teva Pharmaceutical Industries Ltd.  today commented that any launch by Mylan of a generic version of COPAXONE® 40mg/ml…
MS Drug Therapies

October 4, 2017

Two Cytokines Linked to MS Disease Progression

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
OCTOBER 03, 2017 Jared Kaltwasser Scientists have identified 2 cytokines that appear to be tied to the potential for a…
MS Research Study and Reports

October 3, 2017

DEA Clarifies Marijuana Extract Rule and CBD Legality

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
As many of you are aware, on December 14, 2016 the DEA implemented a rule regarding CBD and marijuana extract…
Alternative therapies and devices for Multiple Sclerosis (MS)

October 3, 2017

Long-term Lemtrada Treatment Benefits Demonstrated in Extension Study

  • Lemtrada
    /
  • MS Drug Therapies
    /
October 2, 2017 A five-year study demonstrated that Sanofi-Genzyme’s Lemtrada(alemtuzumab) provides long-term benefits for relapsing-remitting multiple sclerosis patients, reducing relapse rates and preventing…
Lemtrada

October 3, 2017

MS Patients with Poor Diets, Little Exercise Report Higher Pain Levels in Study

  • MS Pain and Side Effects
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Oct 2, 2017 A clear association was seen between the substantial pain that multiple sclerosis (MS) patients experience and lifestyle…
MS Pain and Side Effects

October 3, 2017

Combating Muscle Weakness Associated with MS

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Sometimes walking, even with an assistance device, can be very challenging because of the extreme muscle weakness that I experience.…
Alternative therapies and devices for Multiple Sclerosis (MS)

Categories

Latest Blog Posts